Financial reports
NT 10-K
Notice of late annual filing
1 Apr 19
10-Q
2018 Q3
Quarterly report
14 Nov 18
10-Q
2018 Q2
Quarterly report
10 Aug 18
10-Q
2018 Q1
Quarterly report
22 Jun 18
10-K
2017 FY
Annual report
17 May 18
NT 10-Q
Notice of late quarterly filing
14 May 18
NT 10-K
Notice of late annual filing
29 Mar 18
10-Q
2017 Q3
Quarterly report
14 Nov 17
10-Q
2017 Q2
Quarterly report
14 Aug 17
10-Q
2017 Q1
Quarterly report
15 May 17
Current reports
8-K
W. Austin Lewis IV, Chairman of the Board
6 May 19
8-K
Other Events
23 Apr 19
8-K
Departure of Directors or Certain Officers
18 Mar 19
8-K
Bankruptcy or Receivership
3 Jan 19
8-K
Entry into a Material Definitive Agreement
6 Dec 18
8-K/A
Departure of Directors or Certain Officers
7 Nov 18
8-K
Departure of Directors or Certain Officers
31 Oct 18
8-K
Entry into a Material Definitive Agreement
16 Oct 18
8-K
Entry into a Material Definitive Agreement
1 Oct 18
8-K
Entry into a Material Definitive Agreement
30 Jul 18
Registration and prospectus
15-12G/A
Securities registration termination (amended)
2 Apr 19
15-12G
Securities registration termination
22 Mar 19
D
$1M in equity / debt / options / securities to be acquired, sold $870K, 3 investors
26 Oct 18
D
$1M in equity / debt / options, sold $850K, 2 investors
12 Jul 18
D
$1.5M in equity / debt / options / securities to be acquired, sold $1.19M, 5 investors
22 Feb 18
D
$6.86M in equity / debt / options / securities to be acquired, sold $5.93M, 6 investors
16 Oct 17
D
$4.25M in equity / options, sold $555K, 8 investors
9 Mar 17
D
$3M in equity / options, sold $411.92K, 5 investors
9 Feb 17
D/A
$3M in equity, sold $400K, 7 investors
3 Nov 16
D
$3M in equity, sold $400K, 7 investors
2 Nov 16
Proxies
PRE 14C
Preliminary information
28 Feb 19
DEF 14C
Information statement
6 Sep 18
PRE 14C
Preliminary information
27 Aug 18
DEF 14C
Information statement
11 Aug 17
PRE 14C
Preliminary information
1 Aug 17
DEF 14C
Information statement
21 Mar 17
PRE 14C
Preliminary information
10 Mar 17
DEF 14C
Information statement
7 Dec 16
PRER14C
Preliminary revised information
22 Nov 16
PRE 14C
Preliminary information
16 Nov 16
Other
UPLOAD
Letter from SEC
15 Sep 16
CORRESP
Correspondence with SEC
7 Sep 16
UPLOAD
Letter from SEC
1 Sep 16
CORRESP
Correspondence with SEC
25 Aug 16
UPLOAD
Letter from SEC
28 Jul 16
EFFECT
Notice of effectiveness
28 Aug 08
UPLOAD
Letter from SEC
2 May 06
CORRESP
Correspondence with SEC
29 Aug 05
CORRESP
Correspondence with SEC
12 Aug 05
UPLOAD
Letter from SEC
2 Aug 05
Ownership
SC 13G/A
Medite Cancer Diagnostics, Inc.
2 Nov 18
4
JOHN H ABELES
23 Oct 18
4
William Austin IV Lewis
19 Oct 18
4
William Austin IV Lewis
30 Jul 18
4
Rump Stephen L. Von
30 Jul 18
3
Rump Stephen L. Von
20 Jul 18
4
William Austin IV Lewis
12 Jul 18
4
JOHN H ABELES
10 Jul 18
4
William Austin IV Lewis
5 Jul 18
4
GREGORY FORTUNOFF
8 May 18